REPLICATIVE STRESS PROTEINS AS POTENTIAL PROGNOSTIC MARKERS OF RECURRENCE OF ENDOMETRIOID CARCINOMA OF THE ENDOMETRIUM IN PATIENTS WITH I DISEASE STAGE
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-24-3-2022-g.10827Abstract
Aim: on the basis of bioinformatic analysis of the expression of markers associated with replicative stress, to evaluate their significance in the progression of endometrioid carcinoma of the endometrium (ЕСЕ). Object and methods: the study of ATR, ATM, CHEK1/2, FANCD2, BRCA1 gene expression was carried out using the GEPIA web tool. Bioinformatics databases STRING v.11.5 and FunCoup v.5.0 were used for prognostic modeling of the intergenic interaction of the studied genes. Results: interactive analysis of the gene expression profile in both ЕСЕ and normal tissues revealed that the expression of CHEK1/2, FANCD2, and BRCA1 was higher in ЕСЕ compared to normal tissues. However, the expression of ATR and ATM was significantly lower in ЕСЕ than in the alternative group, which may indicate a malfunction of these genes. Potentially significant biomarkers of genome instability associated with replicative stress ATR, ATM, CHEK1/2, FANCD2 and BRCA1 were determined, reflecting such biological processes as DNA replication and repair. Conclusion: the established highly predictive associations between the studied biomarkers ATM, ATR, CHEK1/2, FANCD2, BRCA1 provide the basis for their further evaluation as informative indicators associated with replicative stress in the progression of endometrioid carcinoma of the endometrium of patients with the I stage of the tumor process.
References
Fedorenko Z, Goulak L, Gorokh Ye, et al. Cancer in Ukraine, 2020-2021. Morbidity, mortality, indicators of the oncology service activity. Bull Natl Cancer Register Ukr. Kyiv, 2022; 23. http://www.ncru.inf.ua/publications/BULL_23/index_e.htm.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (6): 394–24. doi:10.3322/caac.21492.
Hamilton CA, Pothuri B, Arend RC, et al. Endometrial cancer: a society of gynecologic oncology evidence-based review and recommendations, part II. Gynecol Oncol 2021; 160 (3) :827–34. doi: 10.1016/j.ygyno.2020.12.024.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72 (1): 7–33. doi: 10.3322/caac.21708.
Concin N, Matias-Guiu X, Ignace Vergote, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021; 31: 12–39. doi: 10.1136/ijgc-2020-002230.
Ruz-Caracuel I, Ramón-Patino JL, López-Janeiro Á, et al. Myoinvasive pattern as a prognostic marker in low-grade, early-stage endometrioid endometrial carcinoma. Cancers (Basel) 2019; 11 (12): 1845. doi: 10.3390/cancers11121845.
Bendifallah S, Canlorbe G, Collinet P, et al. Just how accurate are the major risk stratification systems for early-stage endometrial cancer? Br J Cancer 2015; 112: 793–801. doi: 10.1038/bjc.2015.35.
Movchan OM, SvintsitskiyVS, Tsip NP et al. Features of recurrence of endometrioid type endometrial cancer of І stage. Exp Oncol 2021; 43 (4): 365–69. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-4.17052.
Kotsantis P, Petermann E, Boulton SJ. Mechanisms of oncogene-induced replication stress: jigsaw falling into place. Cancer Discov 2018; 8 (5): 1–19. doi: 10.1158/2159-8290.CD-17-1461.
Primo LMF, Teixeira LK. DNA replication stress: oncogenes in the spotlight. Genet Mol Biol 2020; 43: e20190138: doi.org/10.1590/1678-4685-GMB-2019-0138.
Kim H, D’Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 2012; 26 (13): 1393-408. doi: 10.1101/gad.195248.112.
Takeuchi M, Tanikawa M, Nagasaka K, et al. Anti-tumor effect of inhibition of DNA damage response proteins, ATM and ATR, in endometrial cancer cells. Cancers (Basel) 2019; 11 (12): 1913. doi: 10.3390/cancers11121913.
Alhmoud JF, Woolley JF, Al Moustafa AE, Malki MI. DNA damage/repair management in cancers. Cancers (Basel) 2020; 12 (4): 1050. doi: 10.3390/cancers12041050.
Segeren HA, Westendorp B. Mechanisms used by cancer cells to tolerate drug-induced replication stress. Cancer Lett 2022; 544: 215804. doi: 10.1016/j.canlet.2022.215804.
Turajlic S, Sottoriva A, Graham T, Swanton C. Resolving genetic heterogeneity in cancer. Nat Rev Genet 2019; 20 (7): 404–16. doi: 10.1038/s41576-019-0114-6.
Sansregret L, Vanhaesebroeck B, Swanton C. Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol 2018; 15 (3): 139–50.
Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018; 174 (6): 1347–60. doi: 10.1016/j.cell.2018.08.027.
Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016; 352 (6282): 169–75. doi: 10.1126/science.aaf2784.
Trautmann K, Terdiman JP, French AJ, et al. Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res 2006; 12 (21): 6379–85. doi: 10.1158/1078-0432.CCR-06-1248.
Buchynska L, Brieieva O, Glushchenko N, et.al. DNA repair deficiency in peripheral blood lymphocytes of endometrial cancer patients with a family history of cancer. BMC Cancer 2014; 14: 765. doi: 10.1186/1471-2407-14-765.
Бучинська ЛГ, Брєєва ОВ, Несіна ІП, та ін. Особливості репарації ДНК у лімфоцитах периферичної крові та пухлинній тканині хворих на рак ендометрію. Онкология 2016; 18 (4): 300–4.
Buchynska LG, Brieieva OV. Sensitivity to 4-hydroxyestradiol and DNA repair efficiency in peripheral blood lymphocytes of endometrial cancer patients. Exp Oncol 2018; 40 (1): 68–72.
Madireddy А, Kosiyatrakul ST, Boisvert RA, et al. Schildkraut FANCD2 facilitates replication through common fragile sites. Molecular Cell 2016; 64: 388–404. doi: 10.1016/j.molcel.2016.09.017.
Gachechiladze M, Skarda J, Bouchalova K, et al. Predictive and prognostic value of DNA damage response associated kinases in solid tumors. Front Oncol 2020; 10: 581217. doi: 10.3389/fonc.2020.581217.
Verlinden L, Bempt IV, Eelen G, et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor−/progesterone receptor−/HER-2−breast carcinomas. Cancer Res 2007; 67: 6574–81. doi: 10.1158/0008-5472.CAN-06-3545.
Madoz-Gúrpide J, Cañamero M, Sanchez L, et al. A proteomics analysis of cell signaling alterations in colorectal cancer. Mol Cell Proteom 2007; 6: 2150–64. doi: 10.1074/mcp.M700006-MCP200.
Fadaka AO, Bakare OO, Sibuyi NRS, Klein A. Gene expression alterations and molecular analysis of CHEK1 in solid tumors. Cancers (Basel) 2020; 12 (3): 662. doi: 10.3390/cancers12030662.
Pichierri P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways. EMBO J 2004; 23 (5): 1178–87. doi: 10.1038/sj.emboj.7600113.
Barlin JN, Soslow RA, Lutz M, et al. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment. Int J Gynecol Cancer 2013; 23 (9): 1620–28. doi: 10.1097/IGC.0b013e3182a5055e.
Soslow RA, Tornos C, Park KJ, et al. Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists. Int J Gynecol Pathol 2019; 38 (Suppl 1): S64–S74. doi: 10.1097/PGP.0000000000000518.
Nepal M, Che R, Ma Chi, et al. FANCD2 and DNA Damage. Int J Mol Sci 2017; 18 (8): 1804. doi: 10.3390/ijms18081804.
Ren L, Chen L, Wu W. Potential biomarkers of DNA replication stress in cancer. Oncotarget 2017; 8 (23): 36996–37008. doi: 10.18632/oncotarget.16940
Ngoi NYL, Sundararajan V, Tan DS. Exploiting replicative stress in gynecological cancers as a therapeutic strategy. Int J Gynecol Cancer 2020; 30 (8): 1224–38. doi: 10.1136/ijgc-2020-001277.
Cleary JM, Aguirre AJ, Shapiro GI, et al. Biomarker-guided development of DNA repair inhibitors. Mol Cell 2020; 78 (6): 1070–85. doi: 10.1016/j.molcel.2020.04.035.
Liao H, Ji F, Helleday T, Ying S. Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments. EMBO Rep 2018; 19 (9): e46263. doi: 10.15252/embr.201846263.
Mhawech-Fauceglia P, Wang D, Kim G, et al. Expression of DNA repair proteins in endometrial cancer predicts disease outcome. Gynecol Oncol 2014; 132 (3): 593–8. doi: 10.1016/j.ygyno.2014.02.002.
